The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2474
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes ; volume:18 ; number:1 ; day:18 ; month:7 ; year:2017 ; pages:1-13 ; date:12.2017
BMC musculoskeletal disorders ; 18, Heft 1 (18.7.2017), 1-13, 12.2017

Schlagwort
Orthopädie

Urheber
De Marco, Gabriele
Beteiligte Personen und Organisationen
Helliwell, Philip
McGonagle, Dennis
Emery, Paul
Coates, Laura C.
Hensor, Elizabeth M. A.
Marzo-Ortega, Helena
SpringerLink (Online service)

DOI
10.1186/s12891-017-1659-1
URN
urn:nbn:de:1111-201708215569
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • De Marco, Gabriele
  • Helliwell, Philip
  • McGonagle, Dennis
  • Emery, Paul
  • Coates, Laura C.
  • Hensor, Elizabeth M. A.
  • Marzo-Ortega, Helena
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Methotrexate

Aufsatzsammlung

Methotrexate

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

High-dose Methotrexate

High-dose Methotrexate

METHOTREXATE INDUCED LEUCOENCEPHALOPATHY

METHOTREXATE INDUCED LEUCOENCEPHALOPATHY

Guide for investigator initiated trials

Guide for investigator initiated trials

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)

Methotrexate intolerance in Rheumatoid Arthritis

Methotrexate intolerance in Rheumatoid Arthritis

Potential neurotoxicity associated with methotrexate

Potential neurotoxicity associated with methotrexate

Methotrexate-Related Pancytopenia: A Case Report

Methotrexate-Related Pancytopenia: A Case Report

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features

Verbundene Objekte